首页 | 本学科首页   官方微博 | 高级检索  
检索        

CD10在儿童期B-急性淋巴细胞白血病中的表达特点及其在微小残留病检测中的意义
引用本文:赵惠君,徐翀,陈静,吴政宏,薛惠良,汤静燕,潘慈,李莉,顾龙君,沈立松.CD10在儿童期B-急性淋巴细胞白血病中的表达特点及其在微小残留病检测中的意义[J].中国实验血液学杂志,2003,11(4):350-354.
作者姓名:赵惠君  徐翀  陈静  吴政宏  薛惠良  汤静燕  潘慈  李莉  顾龙君  沈立松
作者单位:1. 上海第二医科大学附属新华医院,上海儿童医学中心血液肿瘤科,上海,200127
2. 上海第二医科大学附属新华医院,实验诊断中心,上海,200127
摘    要:本研究的目的是观察CDl0在儿童期B急性淋巴细胞白血病(BALL)中的表达情况,并探讨CDl0在白血病微小残留病检测中的应用价值。用流式细胞术分析58例儿童期急性淋巴细胞白血病表型,观察CDl0在BALL病例骨髓细胞中的表达特点,并将CDl0抗体与其它多种抗体构成四色组合用于B-ALL的微小残留病检测,评价其所起到的作用。结果表明,65、5%(38/58)的BALL具有CDl0过强表达(CDl0^bright)的特点,而且CDl0^bright与CD34的阳性表达率有关——CDl0^bright多出现于CD34阳性率高的B-ALL中。CDl0^bright在微小残留病检测中,与其它异常表达的抗原形成的组合能够在双参数点图上很好地区分出白血病细胞群与正常细胞群。即使在其他抗原表达无异常时,也可因CDl0的过强表达而使白血病细胞群与正常细胞群区分开。结论:CDl0^bright与BALL中CD34的高比例表达相关,CDl0^bright也是微小残留病检测的一个很好的指标,CDl0的表达与其他用于微小残留病检测的抗原表达的应用有互补作用。

关 键 词:B-急性淋巴细胞白血病  微小残留病  CDl0  流式细胞术
文章编号:1009-2137(2003)04-0350-05
修稿时间:2002年8月19日

Characterization of CD10 Expression and Its Significance in Minimal Residual Disease Detection in Childhood B-Acute Lymphoblastic Leukemia
Hui-Jun Zhao,Chong Xu,Jing Chen,Zheng-Hong Wu,Hui-Liang Xue,Jing-Yan Tang,Ci Pan,Jing Chen,Li Li,Long-Jun Gu,Li-Song Shen.Characterization of CD10 Expression and Its Significance in Minimal Residual Disease Detection in Childhood B-Acute Lymphoblastic Leukemia[J].Journal of Experimental Hematology,2003,11(4):350-354.
Authors:Hui-Jun Zhao  Chong Xu  Jing Chen  Zheng-Hong Wu  Hui-Liang Xue  Jing-Yan Tang  Ci Pan  Jing Chen  Li Li  Long-Jun Gu  Li-Song Shen
Institution:Department of Hematology/Oncology, Xinhua Hospital, Shanghai 200127, China.
Abstract:To observe the expressions of CD10 in childhood B acute lymphoblastic leukemia (B ALL) and to define the role of CD10 in minimal residual disease (MRD) detection. 58 cases of childhood B ALL were studied in this program. Four color flow cytometry was used to analyze the characteristics of B ALL phenotypes. The four color fluorochrome labeled antibody combinations of CD10 with other markers were used to detect MRD. The results showed that CD10 overexpression (CD10 bright ) was detected in 65.5% (38/58) of B ALL patients and a strong correlation between CD10 bright and CD34 expression was also observed, i.e. CD10 bright expression most frequently happened in B ALL with high percentage of CD34 positive cells. In detection of MRD, CD10 bright , combined with other markers, could effectively distinguish normal cells with leukemic cells, even if there was no any other marker that can be used. It is concluded that CD10 bright expression correlates with high expression of CD34 in B ALL, it is a good marker for MRD detection. The combination of CD10 and other markers can be applied in B ALL MRD detection with flow cytometry.
Keywords:B  acute lymphoblastic leukemia  minimal residual disease  CD10  flow cytometry
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号